Cellectar Biosciences
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-7.3321.733.021.95
Price/Sales ratio
5.312.771.591.09
Earnings per Share (EPS)
$-0.64$0.21$1.55$2.40

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-1.75-1.05-0.86-1.41-0.34-1.24-2.79-1.52-0.42-0.89-0.34-0.34
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
1.323.500.391.780.341.900.751.100.77-2.230.620.34
Price/Cash Flow ratio
-1.60-0.70-0.64-1.74-0.40-1.47-2.95-1.62-0.47-1.04-0.54-0.54
Price/Free Cash Flow ratio
-1.59-0.69-0.63-1.69-0.38-1.47-2.94-1.61-0.47-1.01-43.08-1.47
Price/Earnings Growth ratio
0.030.010.010.040.000.020.040.030.060.03-0.060.02
Dividend Yield
N/AN/AN/A7.53%48.82%N/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
19.27%62.26%52.90%0.28%11.73%1.55%2.23%0.63%0.20%0.15%0.20%1.55%
Return on Assets
-60.40%-72.33%-40.32%-105.36%-87.94%-113.25%-25.15%-64.43%-132.47%-314.54%-132.47%-113.25%
Return On Equity
-75.43%-333.07%-45.64%-126.10%-99.83%-153.14%-26.93%-72.53%-184.43%250.56%-151.20%-153.14%
Return on Capital Employed
-88.03%-462.56%-69.01%-126.44%-99.24%-149.54%-27.75%-72.65%-179.40%293.31%-179.40%-149.54%
Liquidity Ratios
Current Ratio
4.430.737.465.178.604.1116.26N/AN/AN/A3.714.11
Quick Ratio
4.430.737.465.178.604.1116.269.163.710.413.594.11
Cash ratio
4.310.677.004.738.173.8316.048.943.590.373.593.83
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/A0.641.44K220.262.71K2.46K2.50K2.26K3.90K10.66KN/A2.46K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
0.030.040.000.000.000.00N/A0.000.000.000.280.00
Debt Equity Ratio
0.040.200.000.000.000.01N/A0.000.00-0.000.390.00
Long-term Debt to Capitalization
0.020.04N/AN/AN/AN/AN/AN/AN/AN/A0.03N/A
Total Debt to Capitalization
0.040.160.000.000.000.01N/A0.000.00-0.000.030.00
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-5.67KN/A
Cash Flow to Debt Ratio
-19.55-24.68-92.72-3.62K-5.17K-110.43N/A-166.62-496.04-548.95-29.49-5.17K
Company Equity Multiplier
1.244.601.131.191.131.351.071.121.39-0.791.391.13
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.001.001.001.031.031.001.001.001.001.020.011.00
Cash Flow Coverage Ratio
-19.55-24.68-92.72-3.62K-5.17K-110.43N/A-166.62-496.04-548.95-29.49-5.17K
Short Term Coverage Ratio
-72.40-33.38-92.72-3.62K-5.17K-110.43N/A-166.62-496.04-548.95-350.27-5.17K
Dividend Payout Ratio
N/AN/AN/A-10.68%-16.93%N/AN/AN/AN/AN/AN/A-16.93%